Published in Science on December 10, 1948
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med (1974) 4.39
Staining toxoplasma gondii with fluorescein-labelled antibody. II. A new serologic test for antibodies to Toxoplasma based upon inhibition of specific staining. J Exp Med (1957) 3.94
Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol (1980) 3.81
A microplate enzyme-immunoassay for toxoplasma antibody. J Clin Pathol (1976) 3.64
A syndrome resembling progeria: A review of two cases. Arch Dis Child (1950) 3.51
The relationship and significance of antibody titres as determined by various serological methods in glandular and ocular toxoplasmosis. J Clin Pathol (1975) 3.43
Toxoplasmosis: A history of clinical observations. Int J Parasitol (2009) 3.39
A stable haemagglutinating antigen for detecting toxoplasma antibodies. J Clin Pathol (1972) 3.09
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol (1997) 2.84
The histological diagnosis of toxoplasmic lymphadenitis. J Clin Pathol (1961) 2.66
Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol (1981) 2.61
Comparative study of three tests (dye test, indirect haemagglutination test, latex agglutination test) for the detection of antibodies to Toxoplasma gondii in human sera. J Clin Pathol (1982) 2.58
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother (1991) 2.56
The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III. J Exp Med (1949) 2.48
Enzyme-linked immunosorbent assay (ELISA) using antibody class capture for the detection of antitoxoplasma IgM. J Clin Pathol (1982) 2.47
Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis (1996) 2.43
Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol (1997) 2.22
Standardization of the dye test for toxoplasmosis. J Clin Pathol (1952) 2.17
Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol (1988) 2.14
CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol (1991) 2.10
Experimental congenital toxoplasmosis. I. The vagina as a portal of entry of toxoplasma in the mouse. J Exp Med (1950) 1.87
Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group. J Clin Microbiol (1997) 1.85
False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies. Appl Microbiol (1971) 1.85
Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J Clin Microbiol (1996) 1.78
In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrob Agents Chemother (1992) 1.72
Detection of circulating antigen during acute infections with Toxoplasma gondii by enzyme-linked immunosorbent assay. J Clin Microbiol (1977) 1.70
Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry (2009) 1.65
EVALUATION OF IMMUNOFLUORESCENT AND DIRECT AGGLUTINATION METHODS FOR DETECTION OF SPECIFIC TOXOPLASMA ANTIBODIES. Br Med J (1964) 1.62
Age-sex distribution of various diseases with particular reference to toxoplasmic lymphadenopathy. J Hyg (Lond) (1976) 1.61
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. Antimicrob Agents Chemother (1988) 1.61
Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology (1990) 1.61
Micro-agglutination test for toxoplasma antibodies. Immunology (1965) 1.60
A survey of toxoplasmosis in an Ontario community. Can Med Assoc J (1961) 1.60
Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems. J Clin Microbiol (1997) 1.60
Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med (2011) 1.56
Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol (1987) 1.55
Toxoplasmosis II. Studies of Animal Sera Using Complement-Fixation Tests. Can J Comp Med Vet Sci (1963) 1.54
Staining Toxoplasma gondii with fluorescein-labelled antibody. I. The reaction in smears of peritoneal exudate. J Exp Med (1957) 1.54
Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells. Infect Immun (1978) 1.52
Cell-mediated immunity against Besnoitia and toxoplasma in specifically and cross-immunized hamsters and in cultures. J Exp Med (1974) 1.51
Antibody responses to toxoplasma antigens in mice infected with strains of different virulence. Infect Immun (1980) 1.50
Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol (1989) 1.49
Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages. Clin Exp Immunol (1976) 1.48
VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol (2002) 1.45
Toxoplasma antigens recognized by naturally occurring human antibodies. J Clin Microbiol (1986) 1.42
Plate hemolysin test for the rapid screening of toxoplasma antibodies. Appl Microbiol (1974) 1.42
Human toxoplasma infection. J Hyg (Lond) (1954) 1.39
The Toxoplasma gondii oocyst from cat feces. J Exp Med (1970) 1.38
Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infect Immun (1975) 1.38
Immune response and immunopathology during toxoplasmosis. Semin Immunopathol (2012) 1.38
Discrepant toxoplasma latex agglutination test results. J Clin Pathol (1989) 1.37
INDIRECT FLUORESCENT ANTIBODY TECHNIQUE IN THE SEROLOGY OF TOXOPLASMA GONDII. J Clin Pathol (1965) 1.35
Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection. J Clin Microbiol (1989) 1.34
Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infect Dis (1998) 1.32
B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun (2000) 1.31
Some observations on the epidemiology of toxoplasmosis in Canada. J Hyg (Lond) (1976) 1.31
Serology in ocular toxoplasmosis. Br J Ophthalmol (1986) 1.29
The prevalence and epidemiology of toxoplasmosis in Ontario. J Hyg (Lond) (1977) 1.29
Toxoplasma gondii antigens recognized by sequential samples of serum obtained from congenitally infected infants. J Clin Microbiol (1987) 1.28
Biotin-labelled antigen screening test for toxoplasma IgM antibody. J Clin Pathol (1989) 1.25
Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis. Bull World Health Organ (1980) 1.23
Immunohistological study of the anatomic relationship of toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect Immun (1981) 1.22
Identification of an antigen-specific immunoglobulin M antibody associated with acute Toxoplasma infection. Infect Immun (1983) 1.21
Detection of Toxoplasma gondii parasitemia by gene amplification, cell culture, and mouse inoculation. J Clin Microbiol (1992) 1.21
Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of Toxoplasma infection in humans. J Clin Microbiol (1988) 1.21
Common diseases of fur bearing animals I. Diseases of mink. Can Vet J (1966) 1.20
Acquired toxoplasmosis with a report of a case of laboratory infection. Br Med J (1955) 1.17
Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. Infect Immun (1992) 1.17
Toxoplasmosis. Br Med J (1973) 1.16
Toxoplasmic retinochoroiditis. Trans Am Ophthalmol Soc (1960) 1.16
Improved serological diagnosis of Toxoplasma gondii infection by detection of immunoglobulin A (IgA) and IgM antibodies against P30 by using the immunoblot technique. J Clin Microbiol (1992) 1.15
LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol (2008) 1.15
Toxoplasmosis in immunoglobulin M-suppressed mice. Infect Immun (1982) 1.15
A new soluble antigen preparation of Toxoplasma gondii and its use in serological diagnosis. Clin Exp Immunol (1982) 1.14
Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J Clin Microbiol (2005) 1.13
Detection of Toxoplasma gondii antigens by a dot-immunobinding technique. J Clin Microbiol (1985) 1.11
Protective immunity in toxoplasmosis: correlation between antibody response, brain cyst formation, T-cell activation, and survival in normal and B-cell-deficient mice bearing the H-2k haplotype. Infect Immun (1987) 1.11
Toxoplasma antigens recognized by human immunoglobulin A antibodies. J Clin Microbiol (1990) 1.11
Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol (1998) 1.10
Diagnosis of Toxoplasma parasitemia in patients with AIDS by gene detection after amplification with polymerase chain reaction. J Clin Microbiol (1993) 1.10
Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane. J Exp Med (1991) 1.09
Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol (1998) 1.08
An evaluation of the ToxHA test for the detection of antibodies to Toxoplasma gondii in human serum. J Clin Pathol (1980) 1.08
The prevalence of serum antibodies to Toxoplasma gondii in Ontario mammals. Can J Comp Med (1978) 1.07
Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infect Immun (1996) 1.07
Comparison of a latex agglutination test with other serological tests for the measurement of antibodies to Toxoplasma gondii. J Clin Pathol (1984) 1.06
Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors (2015) 1.06
Immunological Study on the Host Cell Penetration Factor of Toxoplasma gondii. Infect Immun (1971) 1.05
Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii. J Exp Med (1992) 1.04
Diagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome by using a new serologic method. J Clin Microbiol (1988) 1.04
Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater accra region of ghana. Ghana Med J (2009) 1.04
Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells. Infect Immun (1990) 1.03
A histological and immunohistochemical study of the changes induced in the brains of white mice by infection with Toxoplasma gondii. Br J Exp Pathol (1984) 1.03
Treatment of uveitis with pyrimethamine (daraprim). Br J Ophthalmol (1956) 1.02
An assessment of a latex agglutination slide test for toxoplasma antibody. J Clin Pathol (1972) 1.02
Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol (2004) 1.02
Infectious mononucleosis and mononucleosis syndromes. West J Med (1977) 1.02
ELISA for toxoplasma antibody detection: a comparison with other serodiagnostic tests. J Clin Pathol (1980) 1.01
Toxoplasmosis In Mink. Can J Comp Med Vet Sci (1958) 1.01
IDENTIFICATION OF THE FILTRABLE, TRANSMISSIBLE NEUROLYTIC AGENT ISOLATED FROM TOXOPLASMA-INFECTED TISSUE AS A NEW PLEUROPNEUMONIA-LIKE MICROBE. Science (1938) 11.12
TOXOPLASMA AND OBLIGATE INTRACELLULAR PARASITISM. Science (1937) 6.75
ISOLATION OF A FILTRABLE, TRANSMISSIBLE AGENT WITH "NEUROLYTI" PROPERTIES FROM TOXOPLASMA-INFECTED TISSUES. Science (1938) 5.54
AN ACQUIRED RESISTANCE OF GROWING ANIMALS TO CERTAIN NEUROTROPIC VIRUSES IN THE ABSENCE OF HUMORAL ANTIBODIES OR PREVIOUS EXPOSURE TO INFECTION. J Exp Med (1936) 5.38
MICE AS CARRIERS OF PATHOGENIC PLEUROPNEUMONIA-LIKE MICROORGANISMS. Science (1939) 4.76
EXPERIMENTAL PROLIFERATIVE ARTHRITIS IN MICE PRODUCED BY FILTRABLE, PLEUROPNEUMONIA-LIKE MICROORGANISMS. Science (1939) 4.64
PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE. Science (1945) 4.05
THE THERAPEUTIC EFFECTIVENESS OF A PRACTICALLY NONTOXIC NEW COMPOUND (CALCIUM AUROTHIOMALATE) IN EXPERIMENTAL, PROLIFERATIVE, CHRONIC ARTHRITIS OF MICE. Science (1940) 3.63
Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol (2000) 3.62
INSECTS AND EPIDEMIOLOGY OF POLIOMYELITIS. Science (1942) 3.59
Visceral lesions in infectious polyneuritis: (Infectious neuronitis, acute polyneuritis with facial diplegia, guillain-barré syndrome, landry's paralysis). Am J Pathol (1941) 3.52
FLIES AS CARRIERS OF POLIOMYELITIS VIRUS IN URBAN EPIDEMICS. Science (1941) 3.48
The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. Am J Public Health (1995) 2.94
Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis (1985) 2.64
Magnetic particle motions within living cells. Measurement of cytoplasmic viscosity and motile activity. Biophys J (1987) 2.62
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Validation of interviewer- and self-administered physical activity checklists for fifth grade students. Med Sci Sports Exerc (1996) 2.30
Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab (1991) 2.27
Prevalence of hypertension, dyslipidemia, and dyslipidemic hypertension. J Fam Pract (1994) 2.21
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care (2000) 2.18
Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int (2007) 2.17
Meningococcal carriage in a population of "normal" families. J Infect Dis (1971) 2.15
The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med (1998) 2.14
Toxoplasmosis. N Engl J Med (1968) 2.11
Three-year maintenance of improved diet and physical activity: the CATCH cohort. Child and Adolescent Trial for Cardiovascular Health. Arch Pediatr Adolesc Med (1999) 2.07
Virus-specific, labile, nonvirion antigen in herpesvirus-infected cells. Proc Natl Acad Sci U S A (1970) 2.04
Pharyngeal pneumococcal acquisitions in "normal" families: a longitudinal study. J Infect Dis (1971) 1.96
School physical education: effect of the Child and Adolescent Trial for Cardiovascular Health. Prev Med (1996) 1.92
Non-medical influences on medical decision-making. Soc Sci Med (1996) 1.92
Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. Anal Biochem (1972) 1.84
The 3/4 mass exponent for energy metabolism is not a statistical artifact. Respir Physiol (1983) 1.74
Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group. Am Heart J (1999) 1.73
Meningococcus and gonococcus: never the Twain--well, hardly ever. N Engl J Med (1971) 1.72
Rapid early action for coronary treatment: rationale, design, and baseline characteristics. REACT Research Group. Acad Emerg Med (1998) 1.69
Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology (2000) 1.65
Environmental endotoxin measurement: the Kinetic Limulus Assay with Resistant-parallel-line Estimation. Environ Res (1992) 1.65
Removal by heparin-MnCl2 of nonspecific rubella hemagglutinin serum inhibitor. Proc Soc Exp Biol Med (1968) 1.63
Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. Am J Med (1982) 1.62
Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis (1981) 1.62
The effects of the Child and Adolescent Trial for Cardiovascular Health upon psychosocial determinants of diet and physical activity behavior. Prev Med (1996) 1.52
Amantadine hydrochloride. Analysis of data related to its proposed use for prevention of A2 influenza virus disease in human beings. JAMA (1967) 1.52
HDL cholesterol: trends in two southeastern New England communities, 1981-1993. Ann Epidemiol (1998) 1.51
Effects of the CATCH physical education intervention: teacher type and lesson location. Am J Prev Med (2001) 1.49
POLIOMYELITIS IN A LABORATORY WORKER EXPOSED TO THE VIRUS. Science (1941) 1.48
IgA proteases of two distinct specificities are released by Neisseria meningitidis. J Exp Med (1980) 1.47
Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. J Clin Epidemiol (1997) 1.45
Callosal dysgenesis in fetuses with ventriculomegaly: levels of agreement between imaging modalities and postnatal outcome. Ultrasound Obstet Gynecol (2012) 1.44
Mortality from pneumonia and risk conditions during influenza epidemics. High influenza morbidity during nonepidemic years. JAMA (1977) 1.40
Intersubject variability in particle deposition does not explain variability in responsiveness to methacholine. Am Rev Respir Dis (1991) 1.40
Amphotericin B therapy in an anephric patient. Antimicrob Agents Chemother (1973) 1.38
THE EFFECT OF FATAL P. KNOWLESI MALARIA ON SIMIAN CIRCULATORY AND BODY FLUID COMPARTMENT PHYSIOLOGY. J Clin Invest (1947) 1.34
Statistical design of the Child and Adolescent Trial for Cardiovascular Health (CATCH): implications of cluster randomization. Control Clin Trials (1995) 1.32
Patient, physician and presentational influences on clinical decision making for breast cancer: results from a factorial experiment. J Eval Clin Pract (1997) 1.31
Cardiovascular risk factors among children after a 2 1/2-year intervention-The CATCH Study. Prev Med (1996) 1.31
Sulfonamide-resistant meningococci. Annu Rev Med (1967) 1.30
Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J Infect Dis (1989) 1.30
NUTRITION AS A FACTOR IN THE DEVELOPMENT OF CONSTITUTIONAL BARRIERS TO INVOLVEMENT OF THE NERVOUS SYSTEM BY CERTAIN VIRUSES. Science (1940) 1.28
Isolation of hartmannella species from human throats. N Engl J Med (1967) 1.26
Cardiovascular risk factors among third grade children in four regions of the United States. The CATCH Study. Child and Adolescent Trial for Cardiovascular Health. Am J Epidemiol (1995) 1.24
Behaviour of Chimpanzee-avirulent Poliomyelitis Viruses in Experimentally Infected Human Volunteers. Br Med J (1955) 1.23
Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) (2000) 1.22
Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res (2000) 1.22
Measurement of self-efficacy for diet-related behaviors among elementary school children. J Sch Health (1995) 1.22
Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA (1965) 1.20
Statistical power for nonequivalent pretest-posttest designs. The impact of change-score versus ANCOVA models. Eval Rev (2001) 1.20
Quantitative biological assay of bacterial endotoxins. Proc Soc Exp Biol Med (1970) 1.19
Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics (1987) 1.18
Theory of protein-ligand interaction. Methods Enzymol (1975) 1.18
Adolescents' eating patterns influence their nutrient intakes. J Am Diet Assoc (2001) 1.18
Oral health status of the elderly in New England. J Gerontol (1993) 1.17
Effect on ventilation of change to the upright posture in newborn infants. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.17
Meningococcal disease, 1965. JAMA (1966) 1.17
Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses. Eur J Epidemiol (1991) 1.15
Convective mixing in human respiratory tract: estimates with aerosol boli. J Appl Physiol (1985) (1988) 1.15
Amantadine and influenza: evaluation of conflicting reports. J Infect Dis (1978) 1.15
Hemophilus influenzae, type b, antibody frequencies determined with bactericidal and radioimmunoassay tests. J Clin Microbiol (1976) 1.14
Herpes simplex and herpes genitalis viruses in etiology of some human cancers. Proc Natl Acad Sci U S A (1973) 1.14
Toxoplasmosis. N Engl J Med (1968) 1.13
Some recollections of the meningococcal diseases. The first Harry F. Dowling lecture. JAMA (1972) 1.13
Vaccination against poliomyelitis in economically underdeveloped countries. Bull World Health Organ (1980) 1.12
Prevalence of marked overweight and obesity in a multiethnic pediatric population: findings from the Child and Adolescent Trial for Cardiovascular Health (CATCH) study. J Am Diet Assoc (2000) 1.11
Perspectives on current use of some virus vaccines in the USA. Measles, rubella, poliomyelitis, and influenza in the USA: contrasts in control by vaccination. Pediatr Res (1979) 1.09
Identification of the activator system for antibody to Toxoplasma as the classical complement pathway. J Infect Dis (1980) 1.08
Serologic epidemiologic studies with M. pneumoniae. I. Demonstration of an hemagglutinin and its inhibition by antibody. Am J Epidemiol (1966) 1.07
Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study. Urology (2001) 1.07
Frequency and cause of disagreements in imaging diagnosis in children with ventriculomegaly diagnosed prenatally. Ultrasound Obstet Gynecol (2010) 1.05
Physician variability and uncertainty in the management of breast cancer. Results from a factorial experiment. Med Care (1998) 1.04
Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc Natl Acad Sci U S A (1992) 1.04
Diet and sex hormone-binding globulin. J Clin Endocrinol Metab (2000) 1.03
Endotoxin measurement: aerosol sampling and application of a new Limulus method. Am Ind Hyg Assoc J (1990) 1.02
Neurodevelopmental outcome of fetuses referred for ventriculomegaly. Ultrasound Obstet Gynecol (2010) 1.01
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA (1999) 1.00
Reproductive capacity and viability at higher temperatures of various transformed hamster cell lines. J Natl Cancer Inst (1969) 0.99
Clinical evaluation of a portable lactate meter in type I glycogen storage disease. J Inherit Metab Dis (2005) 0.99
Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine. Rev Infect Dis (1984) 0.98
A new surrogate variable for erectile dysfunction status in the Massachusetts male aging study. J Clin Epidemiol (2000) 0.98